Anglikang: jointly sign the technology transfer (technical secret) contract with Kerui biology and establish a joint venture
Anglikang announced that it signed the technology transfer (technical secret) contract with the related party Hunan Kerui biopharmaceutical Co., Ltd. as the joint transferee and transferor Central South University, and jointly established a joint venture with Kerui biopharmaceutical. The subject technical achievement is "composition and preparation method of new drug delivery system".
This text is a result of machine translation.
Briefing Updated 5 hours ago
· Real Estate
Relaxed purchase restrictions in Wuhan: families with two and three children can buy the third suite
In-depth
Healthcare, Financials
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Apr 26, 2022 12:26 PM
Apr 21, 2022 07:07 PM
Apr 18, 2022 06:30 PM
Jun 29, 2021 11:48 PM
Briefing Updated 3 hours ago
· Financials
CICC strategy: policies continue to focus on the effectiveness of fundamental repair
Briefing Updated 3 hours ago
· Financials
CITIC Securities: the medium-term slow rise is still in the early stage, and the four main lines continue to rotate
Briefing Updated 3 hours ago
· Real Estate
Changqing District and Zhangqiu District of Jinan are no longer restricted to purchase, and licensed transactions can be conducted after online signing for 2 years
Briefing Updated 27 mins ago
· Financials
Shanghai Baoshan District procuratorate prosecuted a case of embezzlement of epidemic prevention and living security materials
Healthcare, Financials
Electrophysiology AccuPulse Raises Nearly CNY 100 Million in Series A Funding
Founded in November 2020, Suzhou AccuPulse is committed to becoming an international leading platform-based innovative cardiac electrophysiology company. The company has established a research and development team led by well-known electrophysiological experts in the US with R&D centers in Suzhou and in the United States.
May 20, 2022 05:17 PM
Briefing Updated 2 hours ago
· Healthcare
Puli pharmaceutical: iodopanol injection has been approved by the Dutch drug evaluation committee
Briefing Updated 2 hours ago
· Healthcare
Meihua biology: it plans to spend 800 million yuan to 1 billion yuan to buy back the shares of the company
Briefing Updated 2 hours ago
· Healthcare
Three cases of asymptomatic infection were detected in Changbai Korean Autonomous County, Jilin Province
Briefing Updated 10 hours ago
· Real Estate
Wuhan Economic Development Zone has completely abolished the housing purchase restriction policy
See more
Read next
In-depth
Technology
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
Yesterday 12:51 PM
In-depth
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.